CGON (CG Oncology) Float Percentage Of Total Shares Outstanding: 98.24% (As of Jul. 02, 2026)


CGON CG Oncology Inc CGON
12 GF Score
Price $70.89
! 5 Warning Signs
View Full Analysis

What is CG Oncology Float Percentage Of Total Shares Outstanding?

CG Oncology CGON 12 Float Percentage Of Total Shares Outstanding is 98.24% as of Jul. 02, 2026. GuruFocus rates CGON with a GF Score™ of 12/100. The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CG Oncology's float shares is 86.65 Mil. CG Oncology's total shares outstanding is 88.20 Mil. CG Oncology's float percentage of total shares outstanding is 98.24%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CG Oncology's Insider Ownership is 0.93%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CG Oncology's Institutional Ownership is 109.20%.

CGON
12GF Score
CG Oncology Inc CGON
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CG Oncology Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

CG Oncology's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=86.65/88.20
=98.24%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 98.24% mean?
CG Oncology (CGON) has a Float Percentage Of Total Shares Outstanding of 98.24% as of Jul. 02, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on CG Oncology and its competitors.
Is CG Oncology's Float Percentage Of Total Shares Outstanding too high?
CG Oncology's current Float Percentage Of Total Shares Outstanding is 98.24%. Overall, CG Oncology has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does CG Oncology's Float Percentage Of Total Shares Outstanding compare to COGT and SRRK?
CG Oncology's Float Percentage Of Total Shares Outstanding of 98.24% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on CG Oncology and its competitors. CG Oncology's current Float Percentage Of Total Shares Outstanding is 98.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CG Oncology stock overvalued right now?
CG Oncology (CGON) has a current Float Percentage Of Total Shares Outstanding of 98.24%. The current Float Percentage Of Total Shares Outstanding is 98.24%. CG Oncology's overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For CG Oncology (CGON), the current Float Percentage Of Total Shares Outstanding is 98.24% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CG Oncology Business Description

Address 400 Spectrum Center Drive, Suite 2040, Irvine, CA, USA, 92618
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
12GF Score

Get the complete analysis for CGON

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$70.89
Price